from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1089/PE10

LFCtreatmentdescriptionclass of inhibitor

0.381

Amikacinug/mL Amikacintranslation

-1.199

Cap5-10ug/mL Capreomycintranslation

-1.145

Rox10-50 ug/mL Roxithromycintranslation

-0.037

SM2-5 ug/mL Streptomycintranslation

-0.674

Tet5-10 ug/mL Tetracyclinetranslation

0.951

Rif0.2-5ug/mL Rifampicintranscription

1.929

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.203

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.739

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.096

CPZ10-50 ug/mL Chlorpromazinerespiration

0.424

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.488

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.365

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.605

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.805

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.030

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.542

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.084

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.378

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.061

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.349

KCN5-20 ug/mL Potassium cyaniderespiration

-0.598

NaN30.2-2 mM Sodium aziderespiration

-0.889

Nigericin50 uM Nigericinrespiration

0.430

TRC10-150 ug/mL Triclosanrespiration

1.494

TRZ10-25 ug/mL Thioridazinerespiration

-0.458

Valinomycin0.5-10 uM Valinomycinrespiration

-2.372

ZnSO42 mM ZnSO4respiration

-0.396

menadione6-10 ug/mL Menadionerespiration

-0.297

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.006

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.147

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.999

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.167

NRP_1Non-replicating persistence stage 1dosRassociated

-0.051

Amp0.2mg/mL AmpicillincellWall

-0.227

Cephalexin20-100 ug/mL CephalexincellWall

-0.742

Cerulenin0.32-5 ug/mL CerulenincellWall

0.624

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.202

EMB10-20 ug/mL EthambutolcellWall

-0.432

Eta12-40 ug/mL EthionamidecellWall

-0.256

INH0.2-0.4 ug/mL IsoniazidcellWall

0.035

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.144

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.464

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.371

BZA0.12 mg/mL BenzamidearomaticAmides

0.268

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.070

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.178

H2O24 mM hydrogen peroxideDNAdamaging

-0.174

Levo10 ug/mL LevofloxacinDNAdamaging

-0.478

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.898

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.254

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.843

UVUV-irradiationDNAdamaging

1.067

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.245

Antimycin12.5-50 ug/mL Antimycin A?

-0.543

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.632

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.668

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.141

PA8240.2-2 ug/mL PA-824?

0.063

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.347

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.452

Verapamil50 uM Verapamil?

0.352

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.475

methoxatin10-20 ug/mL Methoxatin?